A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback